Leon Nanodrugs

Planegg, Germany · Founded 2010 · Privately Held (backing)

Developer of drugs through nanoscience designed to offer patient outcomes. Leon Nanodrugs is based in Planegg, Germany and was founded in 2010. Its last reported valuation was $71 million in Jul 2015. It has raised $20.5 million.

Last reported valuation

$71.0M

Oct 2026

Priced at

—

Total raised

$20.5M

Last round

—

How much has Leon Nanodrugs raised?

$20.5Macross 0 recorded rounds

Free account

More of Leon Nanodrugs with a free account

·The complete investor list: 11 names
·Watch Leon Nanodrugs: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Leon Nanodrugs investors

11 investors are on record for Leon Nanodrugs, including LBBW Venture Capital, Albany Capital (Australia), Albany Private Equity Holding and Bayerische Beteiligungsgesellschaft.

For fundraisers

Raising for a company like Leon Nanodrugs?

11 investors have backed Leon Nanodrugs.

See all 11 investors →

Frequently asked about Leon Nanodrugs

How much has Leon Nanodrugs raised?: Leon Nanodrugs has raised $20.5M in total across 0 recorded funding rounds.